Navigation Links
Synthetic Biologics Reports Second Quarter 2012 Financial Results
Date:8/14/2012

ANN ARBOR, Mich., Aug. 14, 2012 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of synthetic biologics and innovative medicines for unmet medical needs, today reported financial results for the three and six months ended June 30, 2012 and summarized operational highlights.

Operational HighlightsExpanding Synthetic Biologic Programs

  • Enhanced our relationship with Intrexon by entering into a second worldwide exclusive channel collaboration for the development and commercialization of a series of monoclonal antibody (mAb) therapies for the treatment of certain infectious diseases not adequately addressed by existing therapies. Utilizing Intrexon's comprehensive suite of proprietary technologies, initial discovery efforts will target three infectious disease indications.
  • Initiated preclinical research for the development of a synthetic DNA-based therapy for pulmonary arterial hypertension (PAH), utilizing the UltraVector® platform and RheoSwitch Therapeutic System® of our collaborator, Intrexon.
  • Appointed biologics expert and gene therapy veteran, Michael Kaleko, M.D., Ph.D., to serve as Scientific Director. Dr. Kaleko has worked in the field of gene therapy since its inception in the mid-1980s and has extensive experience developing vector platforms, inducible transcription systems and product candidates in multiple disease areas.
  • Advancing Clinical Trial Programs

  • Strengthened our clinical and regulatory functions by recruiting the former Chief Medical Officer of Clinical Data, Inc., Carol Reed, M.D., to serve as Senior Vice President of Clinical & Regulatory Affairs. Dr. Reed, who led the design and management of two consecutive successful Phase III clinical trials and FDA approval for VIIBRYD®, is responsible for the design and implementation of all aspects of clinical development and clinical trials, as well as regulatory initiatives.
  • Completed e
    '/>"/>

  • SOURCE Synthetic Biologics, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Synthetic Biologics Appoints Carol Reed, M.D., as Senior Vice President of Clinical & Regulatory Affairs
    2. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
    3. Global Spinal Devices and Biologics Market 2011-2015
    4. CMC Biologics Acquires XOMAs Bay Area Manufacturing Facility
    5. Pinnacle Biologics and INTERmedic Medical Devices announce strategic manufacturing and distribution agreement for cancer laser technology
    6. CMC Biologics Achieves Successful Pre-Approval European GMP Inspection by MHRA for Commercial Manufacturing
    7. Chinese Compulsory Immunization Program for Livestock Creates Massive Opportunity for Animal Vaccines and Biologics Developers
    8. Avaxia Biologics Announces Appointment of Michael D. Rivard as VP Corporate Development
    9. CSL Behring Announces FDA Filing of Biologics License Application for 4-Factor PCC for Urgent Reversal of Vitamin K Antagonist Anticoagulant Therapy
    10. Avaxia Biologics is Awarded U.S. Patent for Method to Treat Radiation Damage to the Digestive Tract and Mucositis Caused by Radiation
    11. Althea Technologies Appoints Dr. Kristin DeFife, Director, Biologics Manufacturing And Jack Wright, VP, Sales and Marketing
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/29/2014)... Does your doctor know what you,re smoking?  Chances are, probably ... the over 112,000 currently registered patients under Colorado,s ... roughly 20,300+ active physicians listed with the Colorado Dept of ... though a poll in February 2014 showed 51% of ... "With marijuana legalization underway, every doctor needs ...
    (Date:8/29/2014)... SILVER SPRING, Md. , Aug. 29, 2014 /PRNewswire/ ... today that the U.S. District Court for the District ... in its favor in the company,s case against Sandoz, ... opinion, Judge Peter Sheridan ruled that U.S. ... Sandoz, Inc., and enjoined Sandoz from marketing its generic ...
    (Date:8/29/2014)... , August 29, 2014 ... by Product & Services (Equipment, Reagent, Primer, Probe, ... (Diagnostics, PCR, QPCR, Gene Synthesis, NGS, DNA, RNAi) ... the global Oligonucleotide Synthesis Market is expected to ... in 2014, growing at a CAGR of 9.8% ...
    Breaking Medicine Technology:Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4District Court Decision Received In Remodulin Patent Case 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 3Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 4
    ... Institute researchers are first to associate unique DNA changes ... with several types of renal cell carcinoma, ... (VAI),researchers have identified unique DNA changes in each of several ... kidney cancer in,adults. These findings could aid in the diagnosis ...
    ... Sept. 12 Bionovo, Inc.,(Nasdaq: BNVI ) ... the journal for,the American Society for Pharmacology and ... Vitro Metabolism of,Liquiritigenin, a Bioactive Compound Isolated from ... Liquiritigenin is one of the active compounds of ...
    Cached Medicine Technology:VAI Findings Could Aid Diagnosis and Treatment of Several Types of Kidney Cancer 2Bionovo Reports on Metabolic Studies Related to Its Menopausal Hot Flash Drug Candidate 2Bionovo Reports on Metabolic Studies Related to Its Menopausal Hot Flash Drug Candidate 3
    (Date:8/30/2014)... After offering hyperbaric oxygen therapy ... past several years, Dr. Roy Schmidt and the ... a scholarship program for veterans who have been ... held this summer to discuss veterans’ needs ( ... shed light on the large number of veterans ...
    (Date:8/30/2014)... Seniors Guide, the comprehensive guide to all things senior, ... Disease, Dementia, and Memory Loss . , Country singer Glen ... with the Alzheimer’s, inspired Seniors Guide writers to review the ... movie, out on October 14, 2014, shows a glimpse of ... disease – which inspires a final tour from the musician ...
    (Date:8/30/2014)... August 30, 2014 Continuing to meet ... is expanding with the addition of a new doctor ... who has provided leading-edge skin care in Grand Rapids ... , “As a doctor, my passion is making ... partnering with Forefront Dermatology, I’m better able to focus ...
    (Date:8/30/2014)... August 30, 2014 Hastings and Hastings, ... attorneys located throughout Arizona is pleased to report having ... one specific example among many cases where Hastings and ... able to retain a greater portion of their settlement ... that providing a positive solution for Arizona car accident ...
    (Date:8/30/2014)... Texas (PRWEB) August 30, 2014 ... Oven Industry, 2009-2019 is a professional and in-depth ... industry. The report firstly reviews the basic information ... manufacturing technology. The report then explores global and ... product specification, capacity, production value, and market share ...
    Breaking Medicine News(10 mins):Health News:Tennessee Hyperbaric Center Offering HBOT Scholarships to Veterans 2Health News:Alzheimer’s Disease and Dementia Focus on Retirement Website SeniorsGuideOnline.com 2Health News:Expanding Care at the Forefront of Dermatology 2Health News:Hastings and Hastings Is Pleased To Report Having Saved A Client $67,100 On A Settlement Of $610,000 2Health News:Lab Oven Industry for Global and Chinese Market Forecasts to 2019 in New Research Report Available at ReportsnReports.com 2Health News:Lab Oven Industry for Global and Chinese Market Forecasts to 2019 in New Research Report Available at ReportsnReports.com 3Health News:Lab Oven Industry for Global and Chinese Market Forecasts to 2019 in New Research Report Available at ReportsnReports.com 4
    ... PORTLAND, Ore Newly-published research by scientists at Oregon ... intake is not enough to promote significant weight loss. ... mechanism that reduces a person,s physical activity in response ... in the April edition of the American Journal ...
    ... will present several studies at the American Academy of ... for the treatment of multiple sclerosis (MS) and surprising ... meeting will take place April 10-17 in Toronto. , ... for 6 Months in Patients with Relapsing Multiple Sclerosis: ...
    ... Athletic ... , ... Brook, IL (Vocus) -- AthletiCo Physical and Occupational Therapy recently supported the ... Month) in March. The theme of this year’s NATA Month was ‘Sport Safety is ...
    ... cells to damaged heart tissue , TUESDAY, April 13 (HealthDay ... cells to damaged areas of animal hearts. , The strategy ... retain the cells, potentially boosting the power of cardiac stem ... a treatment for heart injuries, but 24 hours after infusion, ...
    ... ... OxySure has been named as a finalist in the Health category for its ... Awards recognize new companies that will have a significant impact on the environment, ... used to raise funds to support business incubation programs for technology-based entrepreneurs. ...
    ... note that many taking them already face higher risk ... Some anticonvulsants used to treat epilepsy and other conditions ... violent death, a new study finds. , While these ... are also approved treatments for other conditions, such as ...
    Cached Medicine News:Health News:Diet alone will not likely lead to significant weight loss 2Health News:Groundbreaking MS research to be presented at American Academy of Neurology Annual Meeting 2Health News:Groundbreaking MS research to be presented at American Academy of Neurology Annual Meeting 3Health News:Athletico Raises $6,500 For Chicago Hornets Sled Hockey Team 2Health News:Athletico Raises $6,500 For Chicago Hornets Sled Hockey Team 3Health News:Magnets Might Boost Stem Cell Therapy 2Health News:OxySure Systems, Inc. Named Tech Fort Worth IMPACT Awards Finalist 2Health News:OxySure Systems, Inc. Named Tech Fort Worth IMPACT Awards Finalist 3Health News:Study Shows Some Anti-Seizure Meds Raise Suicide Risk 2Health News:Study Shows Some Anti-Seizure Meds Raise Suicide Risk 3
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    Medicine Products: